Red Flags Detected

  • Departure Of Cfo (new) — The Chief Financial Officer resigned to pursue a new opportunity, triggering a leadership transition in the finance function.
NASDAQ: VYGR Voyager Therapeutics, Inc. 8-K

Voyager Therapeutics CFO Nathan Jorgensen resigns; COO Robin Swartz to assume finance role

Filed April 21, 2026 · Period ending April 15, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade VYGR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 1:23 AM